Oncolytics Biotech to Unveil Promising New Data on Anal and Pancreatic Cancer Treatments at 2025 ASCO GI Symposium Oncolytics Biotech will present groundbreaking efficacy and safety data for pelareorep therapy targeting anal and pancreatic cancers at the 2025 ASCO GI Symposium.

Oncolytics Biotech to Unveil Promising New Data on Anal and Pancreatic Cancer Treatments at 2025 ASCO GI Symposium #None #San_Francisco #Oncolytics_Biotech #pelareorep #ASCO_GI

Taiho Oncology to Showcase Crucial Findings at 2025 ASCO GI Symposium Taiho Oncology is set to present significant data at the 2025 ASCO Gastrointestinal Cancers Symposium, highlighting real-world outcomes for patients with metastatic colorectal cancer.

Taiho Oncology to Showcase Crucial Findings at 2025 ASCO GI Symposium #United_States #San_Francisco #Taiho_Oncology #ASCO_GI #metastatic_cancer